Walleye Trading
LGND icon

Walleye Trading’s Ligand Pharmaceuticals LGND Stock Holding History

Walleye Trading’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-132
Closed -$7.79K – 5306
2023
Q3 		$7.91K Buy
+132
New +$8.69K ﹤0.01% 4565
2022
Q2 		– Sell
-3,706
Closed -$260K – 5427
2022
Q1 		$260K Buy
+3,706
New +$269K ﹤0.01% 3567
2019
Q1 		– Sell
-712
Closed -$53.9K – 4499
2018
Q4 		$60K Buy
+712
New +$75.9K ﹤0.01% 4079
2015
Q3 		– Sell
-321
Closed -$20K – 5266
2015
Q2 		$20K Buy
+321
New +$17.5K ﹤0.01% 3979

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's LGND Position: Q4 2023 in Review

Walleye Trading sold out of Ligand Pharmaceuticals (LGND) in Q4 2023, closing a stake of 132 shares — an estimated $7.79K sold.

Walleye Trading first reported a position in LGND in Q2 2015 and held it in 4 quarters. The position peaked at $260K in Q1 2022. 211 funds tracked by Wall St. Rank hold LGND as of Q4 2023.

  • Walleye Trading reported no remaining Ligand Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 132 Ligand Pharmaceuticals shares in Q4 2023, an estimated $7.79K.
  • Walleye Trading first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Walleye Trading's Ligand Pharmaceuticals position peaked at $260K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.